EUVIMEDEUVIMED entdecken
Crossref

Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy

Yuji Maruo iD, Jiro Abe, Hirokuni Yamazawa iD, Atsuhito Takeda iD

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 18.11.2025. Verfasst von Yuji Maruo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

angiotensin‐converting enzyme inhibitordilated cardiomyopathyheart failureinfantileβ‐blocker

Autor:innen und Institutionen

  • Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

ORCID-Profile: Yuji Maruo, Hirokuni Yamazawa, Atsuhito Takeda

Förderung

  • Japan Science and Technology Agency

Zitieren

APA

Maruo, Y., Abe, J., Yamazawa, H., & Takeda, A. (2025). Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70266

Vancouver

Maruo Y, Abe J, Yamazawa H, Takeda A. Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy. Pediatrics International. 2025;67(1). doi:10.1111/ped.70266

BibTeX
@article{Maruo2025,
  author = {Maruo, Yuji and Abe, Jiro and Yamazawa, Hirokuni and Takeda, Atsuhito},
  title = {Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70266}
}
Kostenlos starten →